Press release
Primary Catalyst Driving Coronary Stents Market Evolution in 2025: Rising Prevalence Of Cardiovascular Diseases To Drive Growth In Coronary Stent Market Driver
Coronary Stents Market Size
The market for coronary stents has seen noticeable expansion in the past few years. Its size is projected to increase from $11.06 billion in 2024 to $12.02 billion in 2025, indicating a compound annual growth rate (CAGR) of 8.6%. The surge experienced in the previous years was driven by factors such as the mounting preference for less invasive procedures, improved access to healthcare in developing markets, escalating healthcare spending, a rise in percutaneous coronary interventions, and an expanding populace of cardiologists.
The market for coronary stents is anticipated to experience significant expansion in the coming years, with expectations to reach a value of $16.5 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.3%. This anticipated growth within the forecast period is largely due to the increase in cardiovascular disease cases, an aging demographic, heightened public awareness surrounding cardiovascular health, supportive government initiatives and funding, as well as a rise in lifestyle diseases. Key trends projected for this forecast period encompass advancements in stent and imaging technology, strategic alliances and partnerships, enhancements in stent materials, and technological symbiosis with digital health.
What Factors Are Propelling the Expansion of the Coronary Stents Market?
The anticipated increase in cases of cardiovascular diseases (CVDs) is projected to spur the expansion of the coronary stent market. CVDs represent a variety of heart and blood vessel related ailments including coronary artery disease, heart failure, stroke, and hypertension. The escalation of CVDs can be attributed to factors such as an aging demographic, higher incidences of risk factors like obesity, diabetes, sedentary behavior, unhealthy diets, and stress. Coronary stents are essential in treating CVDs as they have the capability to clear narrowed or blocked coronary arteries, promoting increased blood flow to the heart and lowering chances of heart attacks. For example, an August 2022 study conducted by the American College of Cardiology, a non-profit medical organization based in the U.S., predicted considerable escalations in cardiovascular risk factors in the U.S. from 2025 to 2060. A 39.3% surge is expected in the number of diabetes cases, reaching 55 million individuals, while the cases of dyslipidemia are expected to rise by 27.6% to 126 million. Similarly, hypertension is predicted to increase by 25.1%, affecting 162 million individuals, and obesity will rise by 18.3% to reach 126 million individuals. The most substantial boosts in CVDs are projected to occur in stroke and heart failure cases, with 33.8% (15 million) and 33.4% (13 million) increases respectively. Subsequently, ischemic heart disease is expected to increase by 30.7% (to 29 million) and heart attacks by 16.9% (to 16 million). As a result of this upward trend in CVDs, the coronary stent market is poised for significant growth.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18325&type=smp
Which Key Market Leaders Are Driving Coronary Stents Industry Growth?
Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic Plc, Biosensors International Group Ltd., Boston Scientific Corporation, B. Braun Melsungen AG, Terumo Corporation, W. L. Gore & Associates Inc., Cook Medical Inc., BIOTRONIK SE & Co. KG, Lepu Medical Technology (Beijing) Co. Ltd., Meril Life Sciences Pvt. Ltd, MicroPort Scientific Corporation, OrbusNeich, Asahi Intecc Co. Ltd., Sahajanand Medical Technologies Limited, Translumina GmbH, Stentys S.A., Sorin Group, InspireMD Inc., C. R. Bard Inc., AMG International GmbH, Svelte Medical Systems Inc., Zorion Medical Inc., Spectranetics Corporation
What Are the Emerging Trends in the Coronary Stents Industry?
Leading corporations in the coronary stent market are creating innovative solutions such as drug-eluting stents to minimize the requirement for subsequent procedures in contrast to bare-metal stents. Drug-eluting stents are distinctive coronary stents lacquered with medicine, engineered to avoid arteries from getting clogged again by slowly dispensing drugs over a period of time. For instance, Abbott, an American healthcare firm, introduced the XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India in May 2024. The XIENCE Sierra stent distinguishes itself with its improved structure, novel delivery mechanism and exclusive size choices, particularly planned to tackle challenging cases. It maintains the specially designed coating that reduces the possibility of arteries getting obstructed again, as is customary with other XIENCE stents. This stent comes with an unmatched safety profile, supported by more than 120 clinical studies that involved over 120,000 patients.
What Are the Main Segments in the Coronary Stents Market?
The coronary stents market covered in this report is segmented -
1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents
2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies
3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum-Chromium, Nickel-Titanium, Polymer
4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents
5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses
Subsegments:
1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents
2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents
3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents
4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents
5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents
6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents
7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents
8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents
9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents
Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/coronary-stents-global-market-report
Which Geographic Area Leads the Coronary Stents Market?
North America was the largest region in the coronary stents market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the coronary stents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Is Covered In The Coronary Stents Global Market Report?
- Market Size Analysis: Analyze the Coronary Stents Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Coronary Stents Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Coronary Stents Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Coronary Stents Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18325
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Primary Catalyst Driving Coronary Stents Market Evolution in 2025: Rising Prevalence Of Cardiovascular Diseases To Drive Growth In Coronary Stent Market Driver here
News-ID: 3861100 • Views: …
More Releases from The Business Research Company
Company Registration Service Market Landscape 2025: Forecast Data and Growth Str …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Company Registration Service Market Through 2025?
The market size for company registration services has seen robust growth in the recent past. The market is projected to expand from $10.67 billion in 2024 to $11.55 billion in 2025, exhibiting a compound annual growth…
Comprehensive 2025 Commercial Toilet Partition Market Overview: Trends, Forecast …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Toilet Partition Market Through 2025?
In recent years, the market size for commercial toilet partitions has significantly expanded. The forecast predicts a rise from $1.82 billion in 2024 to $1.95 billion in 2025, with a compound annual growth rate (CAGR) of…
Key Trends Influencing the Growth of the Commercial Insurance For Small And Medi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Commercial Insurance For Small And Medium-Sized Enterprises (SMEs) Market Through 2025?
The market size of commercial insurance for small and medium-sized enterprises (SMEs) has seen substantial growth over the recent years. A rise from $111.83 billion in 2024 to $119.76 billion in…
Growing Focus On Reducing Greenhouse Gas Emissions Driving The Market Growth Due …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Combustion Emissions Analyzer Market Through 2025?
In the past few years, the market size for combustion emissions analyzer has seen robust growth. It is projected to increase from $1.02 billion in 2024 to $1.09 billion in 2025, with a compound annual growth…
More Releases for Stent
Airway Stent Lung Stent Market Size 2024 to 2031.
Market Overview and Report Coverage
An airway stent, also known as a lung stent, is a medical device used to open up blocked airways in the lungs. It is typically used in patients with conditions such as tracheal or bronchial stenosis, tumors, or strictures. The global airway stent lung stent market is expected to grow at a CAGR of 6.10% during the forecasted period.
The future outlook for the airway stent lung…
Airway Stent and Lung Stent Market Revenue Surges: Acumen Research Projection
The airway stent/lung stent market is witnessing a significant surge in revenue, projected to increase by USD 204.4 million by 2032. This growth is driven by a Compound Annual Growth Rate (CAGR) of 6.3% from 2023 to 2032. This article delves into the various facets of the market, including regional dominance, segment growth, and the underlying factors fueling this expansion.
Market Revenue Growth
The global airway stent/lung stent market is on an…
Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the…
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire…
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of…
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients…
